As of 2025-07-04, the Relative Valuation of Axsome Therapeutics Inc (AXSM) is (108.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 103.91 USD, the upside of Axsome Therapeutics Inc based on Relative Valuation is -204.7%.
The range of the Relative Valuation is (103.76) - (104.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.0x - 18.5x | 18.3x |
| Forward P/E multiples | 18.4x - 20.8x | 20.2x |
| Fair Price | (103.76) - (104.78) | (108.79) |
| Upside | -199.9% - -200.8% | -204.7% |
| Date | P/E |
| 2025-07-02 | -18.42 |
| 2025-07-01 | -18.22 |
| 2025-06-30 | -18.47 |
| 2025-06-27 | -18.29 |
| 2025-06-26 | -18.15 |
| 2025-06-25 | -18.35 |
| 2025-06-24 | -18.45 |
| 2025-06-23 | -17.99 |
| 2025-06-20 | -17.82 |
| 2025-06-18 | -18.21 |
| 2025-06-17 | -17.98 |
| 2025-06-16 | -17.99 |
| 2025-06-13 | -18.42 |
| 2025-06-12 | -18.80 |
| 2025-06-11 | -19.12 |
| 2025-06-10 | -19.45 |
| 2025-06-09 | -19.44 |
| 2025-06-06 | -19.80 |
| 2025-06-05 | -19.58 |
| 2025-06-04 | -19.14 |
| 2025-06-03 | -19.48 |
| 2025-06-02 | -19.05 |
| 2025-05-30 | -18.61 |
| 2025-05-29 | -18.52 |
| 2025-05-28 | -18.22 |
| 2025-05-27 | -18.40 |
| 2025-05-23 | -18.59 |
| 2025-05-22 | -18.46 |
| 2025-05-21 | -18.71 |
| 2025-05-20 | -19.17 |
| 2025-05-19 | -19.16 |
| 2025-05-16 | -19.03 |
| 2025-05-15 | -18.97 |
| 2025-05-14 | -18.34 |
| 2025-05-13 | -18.70 |
| 2025-05-12 | -19.49 |
| 2025-05-09 | -19.07 |
| 2025-05-08 | -19.26 |
| 2025-05-07 | -19.62 |
| 2025-05-06 | -19.85 |
| 2025-05-05 | -20.61 |
| 2025-05-02 | -19.86 |
| 2025-05-01 | -19.86 |
| 2025-04-30 | -19.87 |
| 2025-04-29 | -19.45 |
| 2025-04-28 | -18.98 |
| 2025-04-25 | -18.80 |
| 2025-04-24 | -18.65 |
| 2025-04-23 | -18.44 |
| 2025-04-22 | -18.37 |